Cocrystal Pharma, Inc. Email Format

Biotechnology ResearchWashington, United States11-50 Employees

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on discovering and developing antiviral therapies that target the replication machinery of COVID-19 and other coronaviruses, as well as influenza viruses and noroviruses. The company employs structure-based design and expertise linked to Nobel Prize–winning research to pursue antiviral medicines that aim to be first- or best-in-class. It is based in Bothell, Washington, and operates with a small to mid-sized team.

Its development program includes a Phase 1 trial for an influenza A antiviral candidate, and it had planned to initiate COVID-19 clinical studies. Recent updates describe pan-viral direct-acting antivirals with activity against hantavirus, bunyavirus, and influenza. In June 2026, James Sapirstein was appointed Chief Executive Officer.

Sign up for free to view info

Company overview Employee directory